Federal Supply Schedule 36F79722D0128

Roche Diagnostics Corporation, a manufacturer of in vitro diagnostic products, was awarded a Federal Supply Schedule (FSS) contract from the General Services Administration (GSA) to provide medical equipment and supplies to the Department of Veterans Affairs (VA) and other federal agencies. The 5-year, $32.5M contract (FSS-65-VII) covers a range of in vitro diagnostic substances, test kits, and laboratory instruments such as chemistry analyzers, coagulation tests, blood glucose monitors, and associated consumables. Through this IDV contract, the VA VHA and other agency customers can issue firm-fixed price delivery orders and blanket purchase agreements to acquire essential medical equipment and testing supplies to support healthcare services for veterans, active duty military, and other patient populations. The contract does not utilize any small business set-asides, allowing Roche Diagnostics to serve as the prime vendor across orders valued at over $12K to locations nationwide including VA medical centers, Indian Health Service facilities, and military treatment facilities. While the original solicitation details are not provided, the task orders demonstrate how the VA and other federal agencies leverage Roche's established GSA Schedule to efficiently procure high-quality diagnostic products and associated services under standardized pricing and terms.

The work performed under this IDV supports the VA VHA's and other federal agencies' efforts to provide quality healthcare and laboratory testing capabilities for veterans, active duty personnel, and other eligible beneficiaries. Roche Diagnostics has received numerous delivery orders against the FSS contract to supply a wide range of diagnostic equipment, reagents, and test kits. Specific products include chemistry test strips, coagulation test strips and monitoring systems, blood glucose meters and supplies, and other clinical laboratory instruments. These medical supplies and associated services help the VA and other agency customers address the diagnostic testing and monitoring needs of their patient populations in a streamlined, cost-effective manner through an established government-wide contract vehicle.